Skip to main content
Top
Published in: Heart and Vessels 3/2020

01-03-2020 | Intravascular Ultrasound | Original Article

The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system

Authors: Takayuki Yabe, Toshiya Muramatsu, Reiko Tsukahara, Masatsugu Nakano, Hideyuki Takimura, Mami Kawano, Tasuku Hada, Takanori Ikeda

Published in: Heart and Vessels | Issue 3/2020

Login to get access

Abstract

The dynamic coronary roadmap (DCR) is a novel technology that creates a dynamic, motion-compensated, real-time overlay of the coronary arteries on a fluoroscopic image. Whether the DCR reduces contrast volume and enables safe and effective treatment was examined. A total of 146 patients undergoing percutaneous coronary intervention (PCI) from June 2017 to September 2017 in our hospital were retrospectively evaluated. Chronic total occlusion lesions, acute coronary syndrome, and hemodialysis patients were excluded. Patients were divided into the control group (PCI without DCR, 92 patients, 103 lesions) and the DCR group (38 patients, 43 lesions). The primary endpoint was contrast medium volume, and secondary endpoints were radiation dose, fluoroscopy time, and clinical success rate. There was no significant difference in the success rate (100% vs. 100%, P = 1.000) between the groups. Fluoroscopy time (16.3 ± 11.2 min. vs. 11.4 ± 5.5 min, P = 0.007) and contrast medium volume (152.1 ± 73.0 ml vs. 118.8 ± 49.7 ml, P = 0.006) were significantly lower in the DCR group than in the control group. DCR use during PCI was associated with a significant reduction in contrast volume and fluoroscopy time compared to a control group despite similar clinical, lesion, and procedural characteristics.
Literature
1.
go back to reference Navarese EP, Schulze V, Andreotti F, Kowalewski M, Kolodziejczak M, Kandzari DE, Rassaf T, Gorny B, Brockmeyer M, Meyer C, Berti S, Kubica J, Kelm M, Valgimigli M (2015) Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome. JACC Cardiovasc Interv 8:201–213CrossRef Navarese EP, Schulze V, Andreotti F, Kowalewski M, Kolodziejczak M, Kandzari DE, Rassaf T, Gorny B, Brockmeyer M, Meyer C, Berti S, Kubica J, Kelm M, Valgimigli M (2015) Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome. JACC Cardiovasc Interv 8:201–213CrossRef
2.
go back to reference Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264CrossRef Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264CrossRef
3.
go back to reference Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64:442–448CrossRef Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64:442–448CrossRef
4.
go back to reference Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143–149CrossRef Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320:143–149CrossRef
5.
go back to reference Goldenberg I, Chonchol M, Guetta V (2009) Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol 29:136–144CrossRef Goldenberg I, Chonchol M, Guetta V (2009) Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol 29:136–144CrossRef
6.
go back to reference Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29–34CrossRef Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J (2003) A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93:C29–34CrossRef
7.
go back to reference Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr (1999) ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 99:2345–2357CrossRef Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SE, Pepine CJ, Watson RM, Ritchie JL, Gibbons RJ, Cheitlin MD, Gardner TJ, Garson A Jr, Russell RO Jr, Ryan TJ, Smith SC Jr (1999) ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 99:2345–2357CrossRef
8.
go back to reference Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr (1988) Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78:486–502CrossRef Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB III, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr (1988) Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78:486–502CrossRef
9.
go back to reference Abaci O, Harmankaya O, Kocas B, Kocas C, Bostan C, Coskun U, Yildiz A, Ersanli M (2015) Long-term follow-up of patients at high risk for nephropathy after contrast exposure. Angiology 66:514–518CrossRef Abaci O, Harmankaya O, Kocas B, Kocas C, Bostan C, Coskun U, Yildiz A, Ersanli M (2015) Long-term follow-up of patients at high risk for nephropathy after contrast exposure. Angiology 66:514–518CrossRef
10.
go back to reference Shiragami K, Fujii Z, Sakumura T, Shibuya M, Takahashi N, Yano M, Fujii T, Matsuzaki M (2008) Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. Circ J 72:427–433CrossRef Shiragami K, Fujii Z, Sakumura T, Shibuya M, Takahashi N, Yano M, Fujii T, Matsuzaki M (2008) Effect of a contrast agent on long-term renal function and the efficacy of prophylactic hemodiafiltration. Circ J 72:427–433CrossRef
11.
go back to reference Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113:1799–1806CrossRef Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 113:1799–1806CrossRef
12.
go back to reference Lasser EC, Lyon SG, Berry CC (1997) Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 203:605–610CrossRef Lasser EC, Lyon SG, Berry CC (1997) Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology 203:605–610CrossRef
13.
go back to reference Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499CrossRef Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491–499CrossRef
14.
go back to reference Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA (2014) Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv 7:1287–1293CrossRef Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA (2014) Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv 7:1287–1293CrossRef
15.
go back to reference Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, Ratner LE, Collins MB, Moses JW, Kirtane AJ, Stone GW, Karmpaliotis D, Leon MB (2016) Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J 37:3090–3095CrossRef Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, Ratner LE, Collins MB, Moses JW, Kirtane AJ, Stone GW, Karmpaliotis D, Leon MB (2016) Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J 37:3090–3095CrossRef
17.
go back to reference Karimi Galougahi K, Zalewski A, Leon MB, Karmpaliotis D, Ali ZA (2016) Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. Eur Heart J 37:1059CrossRef Karimi Galougahi K, Zalewski A, Leon MB, Karmpaliotis D, Ali ZA (2016) Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration. Eur Heart J 37:1059CrossRef
18.
go back to reference Azzalini L, Mitomo S, Hachinohe D, Regazzoli D, Colombo A (2018) Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography. Can J Cardiol 34:342.e1–342.e3CrossRef Azzalini L, Mitomo S, Hachinohe D, Regazzoli D, Colombo A (2018) Zero-contrast percutaneous coronary intervention guided by dextran-based optical coherence tomography. Can J Cardiol 34:342.e1–342.e3CrossRef
19.
go back to reference Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ (2010) Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 3:346–350CrossRef Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ (2010) Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 3:346–350CrossRef
20.
go back to reference Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914CrossRef Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914CrossRef
21.
go back to reference Gurm HS, Seth M, Dixon SR, Michael Grossman P, Sukul D, Lalonde T, Cannon L, West D, Madder RD, Adam Lauver D (2019) Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions. Catheter Cardiovasc Interv 93:222–230CrossRef Gurm HS, Seth M, Dixon SR, Michael Grossman P, Sukul D, Lalonde T, Cannon L, West D, Madder RD, Adam Lauver D (2019) Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions. Catheter Cardiovasc Interv 93:222–230CrossRef
22.
go back to reference Piayda K, Kleinebrecht L, Afzal S, Bullens R, Ter Horst I, Polzin A, Veulemans V, Dannenberg L, Wimmer AC, Jung C, Bonner F, Kelm M, Hellhammer K, Zeus T (2018) Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study. Eur J Med Res 23:36CrossRef Piayda K, Kleinebrecht L, Afzal S, Bullens R, Ter Horst I, Polzin A, Veulemans V, Dannenberg L, Wimmer AC, Jung C, Bonner F, Kelm M, Hellhammer K, Zeus T (2018) Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study. Eur J Med Res 23:36CrossRef
Metadata
Title
The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system
Authors
Takayuki Yabe
Toshiya Muramatsu
Reiko Tsukahara
Masatsugu Nakano
Hideyuki Takimura
Mami Kawano
Tasuku Hada
Takanori Ikeda
Publication date
01-03-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 3/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01502-1

Other articles of this Issue 3/2020

Heart and Vessels 3/2020 Go to the issue